3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors

US8258151B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Werner Mederski · Zwingenberg, DE
• Norbert Beier · Reinheim, DE
• Bertram Cezanne · Mörfelden, DE
• Rolf Gericke · Seeheim-Jugenheim, DE
• Markus Klein · Weiterstadt, DE
• Christos Tsaklakidis · Weinheim, DE

Key dates

• Filing date: May 25, 2007
• Grant date: Sep 4, 2012
• Expiry date: Mar 31, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel compounds of the formula I, in which X, Y, R, R′, R1, R1′, R1″, R2, R2′, R2″, R3, R3′, R4, R4′ and n have the meanings indicated in Patent Claim 1, are suitable as antidiabetics